Zymeworks (ZYME) Current Assets (2021 - 2026)
Zymeworks recorded quarterly Current Assets of $385.7 million in Q1 2026, up 55.04% quarter-over-quarter from $248.8 million in Q4 2025, and up 25.85% year-over-year from $306.5 million in Q1 2025.
Zymeworks' Current Assets history runs 6 years deep, the most recent figure standing at $385.7 million for Q1 2026.
- In Q1 2026, Current Assets rose 25.85% year-over-year to $385.7 million; the TTM figure through Mar 2026 stood at $385.7 million (up 25.85% YoY), while the FY2025 annual figure was $248.8 million, down 17.2% from the prior year.
- Current Assets came in at $385.7 million for Q1 2026 at Zymeworks, up from $248.8 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $544.7 million in Q4 2022 to a low of $190.7 million in Q3 2022.
- A 5-year average of $354.7 million and a median of $374.6 million in 2023 frame the typical range for Current Assets.
- Across the five-year window, Current Assets jumped 96.5% in 2023 and fell 27.24% in 2024, its largest moves.
- Zymeworks' Current Assets stood at $544.7 million in 2022, then declined by 24.19% to $412.9 million in 2023, then decreased by 27.24% to $300.5 million in 2024, then decreased by 17.2% to $248.8 million in 2025, then jumped by 55.04% to $385.7 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $385.7 million, $248.8 million, and $291.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 10.37 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 37.31 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.25 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 73.04 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 3.59 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 11.73 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 18.21 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.22 Bn |
| 10 | Zymeworks | 1.84 Bn | 1.47 Bn | - | 385.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 385.68 Mn |
| Dec 31, 2025 | 248.77 Mn |
| Sep 30, 2025 | 291.71 Mn |
| Jun 30, 2025 | 296.13 Mn |
| Mar 31, 2025 | 306.47 Mn |
| Dec 31, 2024 | 300.45 Mn |
| Sep 30, 2024 | 343.77 Mn |
| Jun 30, 2024 | 383.50 Mn |
| Mar 31, 2024 | 393.82 Mn |
| Dec 31, 2023 | 412.93 Mn |
| Sep 30, 2023 | 374.63 Mn |
| Jun 30, 2023 | 420.34 Mn |
| Mar 31, 2023 | 426.37 Mn |
| Dec 31, 2022 | 544.71 Mn |
| Sep 30, 2022 | 190.66 Mn |
| Dec 31, 2021 | 288.22 Mn |